For the microtiter assay, 90 µL of the mixture of luminol and H 2 O 2 (1/1, v/v) was added to a well of the clear 96-well microtiter plate. Then 10 µL of HRP-streptavidin solution with varying concentrations (10 −7 , 10 −6 , 10 −5 , 10 −4 , and 10 −3 g/mL) was added to the above wells in duplicate. In addition, 90 µL of the mixture of luminol and H 2 O 2 (1/1, v/v) was also used as a negative control. The intensities of the chemiluminescent signal generated were detected by a CCD imager and quantified using ImageJ image analysis program (NIH). The CCD images shown that intensities of the chemiluminescent signal generated for the concentrations of 10 −7 and 10 −6 g/mL were very weak and close to the results of the negative control; The signal intensities for the concentrations of 10 −4
and 10 −3 g/mL were very strong; The signal intensity for the concentrations of 10 −5 g/mL was obviously stronger and weaker than those of negative control, and the concentrations of 10 −4 and 10 −3 g/mL,
respectively (see the Figure S1 below). [HRP-streptavidin] Optimization 10-7 g/ml 10-6 g/ml 10-5 g/ml 10-4 g/ml 10-3 g/ml
The intensities of chemiluminescence signals were also quantified by using a multi-mode microplate reader (Synergy TM 2, BioTek Instruments, Inc., Winooski, VM, USA). Firstly, 90 µL of the mixture of luminol and H 2 O 2 (1/1, v/v) was added to a well of the black 96-well microtiter plate. Then 10 µL of HRP-streptavidin solution with varying concentrations (10 −7 , 10 −6 , 10 −5 , 10 −4 , and 10 −3 g/mL) was added to the above wells in duplicate. In addition, 90 µL of the mixture of luminol and H 2 O 2 (1/1, v/v) was also used as a negative control. Finally, the intensities of the chemiluminescent signals generated were continuously detected and recorded with 1 min of time interval. The signal intensities as a function of time at different HRP-streptavidin concentrations were shown in Figure S1 , which demonstrated the similar results to the CCD imager testing. Therefore 10 −4
and 10 −3 g/mL were chosen as two quantity levels of HRP-streptavidin to prepare the conjugate pad in order to obtain low limits of detection. Although the initial HRP-streptavidin concentrations were screened on a microtiter plate, two concentrations (10 −4 and 10 −3 g/mL) were examined on the lateral flow. Experimental results from the lateral flow assay demonstrated that chemiluminescence signals at HRP-streptavidin concentrations of 10 −4 and 10 −3 g/mL were strong (we also did experiments for the concentration of 10 −5 g/mL, but the signals were very weak, so we did not report). Therefore, two concentrations of HRP-streptavidin conjugate were used to prepare the conjugate pad (10 
